ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Featured Clinical Trial: First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer
PsycEXTRA Dataset
◽
10.1037/e403762005-006
◽
2005
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Metastatic Breast Cancer
◽
Postmenopausal Women
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
Abstract P6-17-14: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical trial for the SBCCSG-36 investigators
10.1158/1538-7445.sabcs18-p6-17-14
◽
2019
◽
Author(s):
K Inoue
◽
J Ninomiya
◽
K Okubo
◽
T Nakakuma
◽
H Yamada
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
First Line
◽
Her2 Positive
◽
Open Label
◽
First Line Therapy
◽
Line Therapy
◽
Open Label Phase
Download Full-text
Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial
Investigational New Drugs
◽
10.1007/s10637-019-00773-9
◽
2019
◽
Vol 37
(3)
◽
pp. 592-593
Author(s):
Kenichi Inoue
◽
◽
Jun Ninomiya
◽
Tsuyoshi Saito
◽
Katsuhiko Okubo
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Metastatic Breast
◽
First Line
◽
Her2 Positive
◽
Open Label
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Exemestane as First-Line Therapy in Postmenopausal Women With Recurrent or Metastatic Breast Cancer
American Journal of Clinical Oncology
◽
10.1097/coc.0b013e31819fdf9b
◽
2009
◽
pp. 1
◽
Cited By ~ 1
Author(s):
Stefan Glück
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Postmenopausal Women
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial
Investigational New Drugs
◽
10.1007/s10637-019-00755-x
◽
2019
◽
Vol 37
(3)
◽
pp. 538-547
◽
Cited By ~ 3
Author(s):
Kenichi Inoue
◽
◽
Jun Ninomiya
◽
Tsuyoshi Saito
◽
Katsuhiko Okubo
◽
...
Keyword(s):
Breast Cancer
◽
Clinical Trial
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Metastatic Breast
◽
First Line
◽
Her2 Positive
◽
Open Label
◽
First Line Therapy
◽
Line Therapy
Download Full-text
S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226.
10.1158/0008-5472.sabcs11-s1-1
◽
2011
◽
Cited By ~ 5
Author(s):
RS Mehta
◽
WE Barlow
◽
KS Albain
◽
T Vandenberg
◽
SR Dakhil
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Randomized Trial
◽
Postmenopausal Women
◽
Metastatic Breast
◽
Phase Iii
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
WITHDRAWN: Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group
The Breast
◽
10.1054/brst.2002.0469
◽
2002
◽
Author(s):
B. Ejlertsen
◽
I. Højris
◽
S. Hansen
◽
K. Møholt
◽
B. Kristensen
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Pilot Study
◽
Metastatic Breast
◽
Cooperative Group
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial
British Journal of Cancer
◽
10.1038/sj.bjc.6603351
◽
2006
◽
Vol 95
(7)
◽
pp. 788-793
◽
Cited By ~ 43
Author(s):
A Chan
◽
◽
M Martin
◽
M Untch
◽
M G Gil
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Cancer Patients
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Breast Cancer Patients
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Her 2
Download Full-text
Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer
The Oncologist
◽
10.1634/theoncologist.7-5-410
◽
2002
◽
Vol 7
(5)
◽
pp. 410-417
◽
Cited By ~ 107
Author(s):
Mohammad Jahanzeb
◽
Joanne E. Mortimer
◽
Furhan Yunus
◽
David H. Irwin
◽
James Speyer
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Final results from PERUSE, a global study of pertuzumab (P), trastuzumab (H) and investigator’s chosen taxane as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)
10.1055/s-0041-1730221
◽
2021
◽
Author(s):
A Schneeweiss
◽
D Miles
◽
E Ciruelos
◽
F Puglisi
◽
T Peretz-Yablonski
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
First Line
◽
Her2 Positive
◽
First Line Therapy
◽
Line Therapy
◽
Global Study
◽
Locally Recurrent
Download Full-text
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan
Anti-Cancer Drugs
◽
10.1097/cad.0b013e328302eb15
◽
2008
◽
Vol 19
(7)
◽
pp. 753-759
◽
Cited By ~ 8
Author(s):
Nahomi Tokudome
◽
Yoshinori Ito
◽
Kiyohiko Hatake
◽
Masakazu Toi
◽
Muneaki Sano
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Pharmacokinetic Study
◽
Metastatic Breast
◽
First Line
◽
First Line Therapy
◽
Multicenter Phase
◽
Line Therapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close